Mirae Asset Healthcare Fund · Regular · Growth
NAV
₹41.8100
as of 16 Jun 2026
Expense Ratio
1.93%
AUM
₹2,756 Cr
Lumpsum returns (CAGR)
- 1Y
- +9.61%
- 3Y
- +23.11%
- 5Y
- +14.03%
- Since Inception
- +19.70%
SIP returns (XIRR)
- 1Y
- +16.59%
- 3Y
- +15.83%
- 5Y
- +16.71%
- Since Inception
- +19.53%
Beat the benchmark — ₹500/month SIP
Same SIP in this fund vs the benchmark index
This fund
₹1,05,069
Benchmark
₹82,573
+₹22,496 extra wealth vs the benchmark index
Backtest this SIP yourselfSIP since inception — what ₹500/month became
Real NAV backtest from day one
₹47,500
Invested
₹1,05,069
Value today
19.7%
XIRR (p.a.)
₹500/month SIP from fund inception · Current value as of today
Try SIP Calculator with this fund's history₹1,000 lumpsum at launch — value today
Invested on the fund's first NAV date
₹1,000
Invested
₹4,209
Value today
19.8%
CAGR (p.a.)
One-time investment at fund inception · Growth purely from NAV appreciation
Try Lumpsum Calculator₹10L corpus with ₹5,000/month withdrawals since inception
Corpus is still growing despite monthly payouts
₹10,00,000
Initial corpus
₹4,75,000
Withdrawn
₹31,58,207
Corpus left
+₹26,33,207 net gain — withdrew ₹4,75,000 AND corpus grew
Plan your SWP with real NAV₹6L corpus via 12-month STP from a liquid fund at inception
₹50K/month transferred from HDFC Liquid → this fund at launch
₹6,00,000
Invested
₹24,50,220
Value today
-3.0%
vs lumpsum
Direct lumpsum would have beaten STP by 3.0% — but STP reduced timing risk
Model your own STP with real NAV₹1 lakh on the worst crash day — 22 Mar 2020
Worst single-day Nifty drop during this fund's life
₹1,00,000
Invested
₹4,35,028
Value today
4.3×
Multiple
Staying invested through that crash turned ₹1L into ₹4,35,028 — a 4.3× return
Read: Staying invested through crashesRisk Metrics
Trailing 1 year, annualised0.05
Sharpe Ratio
+0.04
Alpha
0.32
Beta
0.05
Sortino
15.53%
Std Dev
-16.09%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Mar 2026- Pharmaceuticals & Biotechnology78.00%
- Healthcare Services21.00%
- IT - Services1.00%
- Chemicals & Petrochemicals1.00%
Each sector links to the mutual funds most exposed to it.
Thinking about Mirae Asset Healthcare Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
- 1Sun Pharmaceutical Industries Ltd.12.20%
- 2Divi'S Laboratories Ltd.7.93%
- 3Glenmark Pharmaceuticals Ltd.6.94%
- 4Jb Chemicals & Pharmaceuticals Ltd.6.88%
- 5Apollo Hospitals Enterprise Ltd.6.15%
- 6Lupin Ltd.5.06%
- 7Aurobindo Pharma Ltd.4.32%
- 8Dr. Reddy'S Laboratories Ltd.4.31%
- 9Fortis Healthcare Ltd.3.73%
- 10Laurus Labs Ltd.3.56%
Investment Objective
Mirae Asset Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Mirae Asset Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by Mirae Asset Mutual Fund. The fund has been operational for over 7 years. It manages assets worth ₹2,756 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against NIFTY 500 TRI. The current expense ratio is 1.93%.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations